vimarsana.com

Page 5 - Pherecydes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pherecydes Pharma Organizes a Scientific Symposium During the 23rd National Days of Infectiology

Phage therapy in 2022: French experience Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE, PEA-PME eligible), a biotech company specializing in precision phage therapy to treat resistant

Pherecydes pharmaArthur rouillDusan oresanskyPascal birmanNational days of infectiologyBordeaux university hospitalPalais des congrNational daysDiabetic footMedical directorFrench national agency

The General Assembly of Pherecydes Pharma Approves the Evolution of Its Governance Towards a Company with a Board of Directors

The new Board of Directors has appointed Didier Hoch as Chairman and CEO, and Thibaut du Fayet as Deputy CEO Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE, éligible PEA-PME) (Paris:ALPHE)

France generalArthur rouillPherecydes pharmaDidier hochDusan oresanskyCombined general meetingSupervisory boardGuy charles fanneau de la horieExecutive boardShareholders general meetingsFrench national agency

Pherecydes Pharma Announces the First International Approval of a Compassionate Treatment With Its Phages

The Swedish Medical Products Agency (SMPA) has given its approval to treat a compassionate case of osteoarticular infection of a prosthetic joint with the Company's anti-S. aureus phages Regulatory

France generalUppsala lanArthur rouillPherecydes pharmaDusan oresansky olivier bricaudSwedish medical products agencyCharles fanneau de la horieExecutive boardFrench national agencyOresansky olivier bricaud

Pherecydes Pharma Announces the Appointment of Thibaut du Fayet as Chief Operating Officer and Member of the Executive Board

Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections

France generalArthur rouillPherecydes pharmaDusan oresansky olivier bricaudVp corporate developmentBusiness schoolRegulatory newsExecutive boardChief operatingSenior managing directorStrategy directorStrategic marketing directorAlliances programs managementCharles fanneau de la horieChief operating officerFrench national agency

Pherecydes Pharma Granted a New Patent for Its anti-Pseudomonas aeruginosa Phages in Europe

Regulatory News: Pherecydes Pharma (FR0011651694 ALPHE) (Paris:ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complicated bacterial infections

United statesFrance generalHong kongArthur rouillPherecydes pharmaDusan oresansky olivier bricaudEuropean patent officeRegulatory newsCharles fanneau de la horieExecutive boardFrench national agencyOresansky olivier bricaud

vimarsana © 2020. All Rights Reserved.